Eli Lilly’s engineered peptide drugs Mounjaro and Zepbound are once-weekly injectable products, formulations that are expensive to manufacture and burdensome to patients who dislike needles. Lilly ...
Health informatics leaders at NYU Langone Health think fully autonomous clinical AI is coming in the next five years or so, ...
More than 400 rural hospitals across the country are at risk of closure, battling a mix of reimbursement issues, workforce struggles and policy decisions that have left safety net providers ...
For healthcare leaders evaluating procurement options or clinicians recommending at-home care, selecting the right gel pack supplier requires careful evaluation of durability, temperature retention, ...
NationsBenefits, a fintech, benefits and outcomes platform, has acquired food-as-medicine company Good Measures, the companies announced Tuesday. Plantation, Florida-based NationsBenefits is a ...
Healthcare leaders must resist using AI as a substitute for staffing. Instead, invest in workforce optimization technology that empowers nurses, creates flexible pathways, and addresses the systemic ...
ICHRA — Individual Coverage Health Reimbursement Arrangement — seems to be the new buzzword of 2025. The interest in ICHRA stems from dissatisfaction with traditional group health insurance. The ...
How can a biotech startup raise more than $1 billion over four plus years and say almost nothing publicly along the way? For Treeline Biosciences, the silence was strategic. Out of view of prying eyes ...
Accountable care organizations (ACOs) in the Medicare Shared Savings Program saved $2.4 billion in 2024, according to data released last week by the Centers for Medicare and Medicaid Services (CMS).
In a Friday letter, a group of pharmacy organizations called on Congressional leadership to take action on pharmacy benefit manager reform. The organizations included in the letter are the National ...
A Hengrui Pharma obesity drug designed to hit two targets led to an average of nearly 18% weight loss in a pivotal study, paving the way for a regulatory submission in China, where the trial was ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results